Use of Dupilumab Reduced Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis with Nasal Polyps

Dupilumab Leads to Improved Quality-of-Life in Patients with Chronic Rhinosinusitis with Nasal Polyps

Use of Multiple Concurrent Biologic Therapies: A Potential New Treatment Option for Patients with Refractory CRSwNP and Asthma

Dupilumab Shows Promising Results in Improving Health-Related Quality of Life for Patients with Chronic Rhinosinusitis with Nasal Polyps

The American Rhinologic Society Heads to COSM 2023
in Boston, May 4-5

2023 Spring Meeting of the American Rhinologic Society at COSM

×
Advertisement